REG - Geiger Counter Ltd Geiger Counter - GCS - Publication of Prospectus

Geiger CounterAnnouncement

22/11/2024 12:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241122:nRSV3680Na&default-theme=true

RNS Number : 3680N  Geiger Counter Ltd  22 November 2024

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE
OR IN PART, TO US PERSONS OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA,
CANADA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION WHERE, OR TO ANY
OTHER PERSON TO WHOM, TO DO SO WOULD BE UNLAWFUL. THE INFORMATION CONTAINED
HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO SELL OR ISSUE, OR ANY
SOLICITATION OF ANY OFFER TO PURCHASE, SUBSCRIBE FOR OR OTHERWISE ACQUIRE, ANY
INVESTMENTS IN ANY JURISDICTION

 

22 November 2024

GEIGER COUNTER LIMITED

("GCL" OR THE "COMPANY")

 

Publication of Prospectus

The Board of the Company today announces the publication of a prospectus (the
"Prospectus") in relation to the admission of its ordinary shares to the to
the Official List of the FCA and to trading on the London Stock Exchange's
Main Market (the "Admission"), the 2025 Subscription Rights Issue and the
Placing Programme. The Board has also approved the cancellation of the listing
of the Company's ordinary shares on The International Stock Exchange (the
"TISE Cancellation"). Application has been made for the admission of the
Company's ordinary shares to the Official List of the Financial Conduct
Authority and to trading on London Stock Exchange plc's Main Market for listed
securities with Admission and the TISE Cancellation expected to become
effective on or around 28 November 2024.

A copy of the Prospectus will be submitted to the National Storage Mechanism
and will be available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)  shortly as well as
on the Company's website at https://ncim.co.uk/geiger-counter-ltd/
(https://ncim.co.uk/geiger-counter-ltd/) .

Unless otherwise defined, the terms used in this announcement shall have the
same meaning as set out in the Prospectus.

Enquiries

 Manulife | CQS                          Craig Cleland                              T: +44 (0) 20 7201 5368

 Cavendish Capital Markets Limited       Tunga Chigovanyika (Corporate Finance)     T: +44 (0) 20 7397 1915

                                         Daniel Balabanoff / Pauline Tribe (Sales)  T: +44 (0) 20 7220 0517

 R&H Fund Services (Jersey) Limited      Jane De Barros                             T :+44 (0) 1534 825 259

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PDIFEAFEEELSEFF